Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of cancer globally
3.2.1.2 Several initiatives undertaken by government and other organizations to spread disease awareness
3.2.1.3 Growing number of diagnostic laboratories in developing countries
3.2.1.4 Technology advancements in developed countries
3.2.2 Industry pitfalls and challenges
3.2.2.1 High capital investment coupled with high costs associated with diagnostic imaging systems
3.2.2.2 Risk related with high radiation exposure affecting use of CT scanner
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Tumor biomarkers tests
5.3 Imaging
5.3.1 Ultrasound and radiology
5.3.2 Mammography
5.3.3 MRI scan
5.3.4 PET scan
5.3.5 CT scan
5.3.6 SPECT and other imaging
5.4 Biopsy
5.5 Liquid biopsy
5.6 Immunohistochemistry
5.7 In situ hybridization
Chapter 6 Market Estimates and Forecast, By Cancer Type, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Bladder cancer
6.3 Breast cancer
6.4 Colon and rectal cancer
6.5 Endometrial cancer
6.6 Kidney cancer
6.7 Leukemia
6.8 Liver and lung cancer
6.9 Melanoma
6.10 Non-hodgkin lymphoma
6.11 Pancreatic cancer
6.12 Prostate cancer
6.13 Thyroid cancer
6.14 Other cancer types
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Diagnostic laboratories
7.4 Diagnostic imaging centers
7.5 Cancer research institutes
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 AB Sciex Pte
9.3 Agilent Technologies
9.4 Becton, Dickinson and Company
9.5 Biocare Medical
9.6 Biocartis
9.7 Biomerieux
9.8 Bio-Rad Laboratories
9.9 Danaher Corporation
9.10 F-Hoffmann-La Roche
9.11 GE Healthcare
9.12 Hologic
9.13 Johnson & Johnson
9.14 Koninklijke Philips
9.15 Myriad Genetics
9.16 QIAGEN
9.17 Siemens Healthineers
9.18 Sysmex Corporation
9.19 Thermo Fisher Scientific
